生化试剂市场 - 按产品类型（PCR、细胞和组织培养、电泳和色谱试剂）、应用（基因组学、蛋白质组学、诊断、药物发现和开发）、最终用途 - 全球预测（2024 - 2032）

在个人化医疗日益转变的推动下，全球生化试剂市场预计从 2024 年到 2032 年复合年增长率将超过 8.5%。随着医疗保健转向基于个人基因图谱的客製化治疗，对用于基因测试和分子诊断的生化试剂的需求不断增加。这些试剂在识别影响疾病易感性和治疗反应的遗传变异和生物标记方面发挥着至关重要的作用。

在此背景下，2024 年 7 月，威斯康辛州生物健康技术中心获得了 4,900 万美元的联邦资金，用于推动精准医疗。该投资旨在促进个人化医疗领域的创新、生产能力和劳动力发展。

这一趋势反映了对精准医疗保健的更广泛重视，其中准确和特定的生化检测对于开发标靶疗法和改善患者治疗结果以及繁荣研究、诊断和治疗应用市场向前发展至关重要。

整个生化试剂市场根据产品类型、应用、最终用途和地区进行分类。

基因组学领域将在 2024 年至 2032 年期间呈现出显着的复合年增长率。由于基因组研究和个人化医疗的进步，基因组学领域将经历高潮。这些试剂对于基因组学中的 DNA 定序、PCR 扩增和基因表现分析等任务至关重要。随着在理解遗传变异、疾病机制和治疗标靶方面的应用不断增加，生化试剂能够实现精确、高效的基因组分析。这种能力支持开发针对个别基因图谱的个人化疗法，增加了对高品质试剂的需求，以确保基因组研究和临床诊断的准确性和可靠性。

到2032年，细胞和组织培养领域将获得前景看好的生化试剂市场份额。这些试剂在受控实验室环境中维持细胞活力、生长和分化方面发挥着至关重要的作用。随着在药物开发、再生医学和生物加工中的应用不断增加，生化试剂促进了细胞和组织的培养和操作，以用于各种研究和治疗目的。它们在确保基于细胞的测定和实验的可重复性和可靠性方面的作用强调了它们在推进生物医学科学和满足生物製药行业不断变化的需求方面的重要性。

2024年至2032年期间，欧洲生化试剂市场将以令人印象深刻的复合年增长率成长。欧洲对生物製药和个人化医疗研发的重视正在放大对先进生化试剂的需求。此外，确保高标准研究和诊断的严格监管框架正在为生化试剂行业的扩张创造有利的环境。慢性病盛行率的增加和人口老化也导致需求增加，因为生化试剂在疾病诊断、治疗监测和治疗开发中发挥关键作用。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 增加生命科学和生物技术领域的研发活动
    • 慢性病和传染病的发生率上升
    • 生化研究的技术进步
  • 产业陷阱与挑战
    • 生化试剂成本高
    • 严格的监管政策和品质控制标准
• 成长潜力分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 竞争定位矩阵
• 战略展望矩阵

第 5 章：市场估计与预测：按产品类型，2021 - 2032

• 主要趋势
• 聚合酶炼式反应试剂盒
• 细胞和组织培养试剂
• 电泳试剂
• 色谱试剂
• 其他产品类型

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 药物发现与开发
• 基因组学
• 蛋白质体学
• 诊断
• 生物技术研究
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 生物技术和製药公司
• 学术及研究机构
• 医院和诊断实验室
• 合约研究组织 (CRO) 和合约开发和製造组织 (CDMO)

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Abbott Laboratories
• Agilent Technologies Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• F. Hoffmann-La Roche Ltd.
• Johnson and Johnson
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Waters Corporation

Global Biochemical Reagents Market will infer over 8.5% CAGR from 2024 to 2032, driven by the growing shift toward personalized medicine. As healthcare moves toward tailored treatments based on individual genetic profiles, there is a heightened demand for biochemical reagents used in genetic testing and molecular diagnostics. These reagents play a crucial role in identifying genetic variations and biomarkers that influence disease susceptibility and treatment response.

Against this backdrop, in July 2024, Wisconsins Biohealth Tech Hub secures USD 49 million in federal funding to advance precision medicine. The investment aims to boost innovation, production capabilities, and workforce development within the personalized medicine sector.

This trend reflects a broader emphasis on precision healthcare, where accurate and specific biochemical assays are essential for developing targeted therapies and improving patient outcomes, thriving the market forward in research, diagnostics, and therapeutic applications.

The overall biochemical reagents market is categorized based on product type, application, end-use, and region.

The genomics segment will exhibit a remarkable CAGR during 2024-2032. The genomics segment will experience an upsurge due to advancements in genomic research and personalized medicine. These reagents are essential in genomics for tasks such as DNA sequencing, PCR amplification, and gene expression analysis. With increasing applications in understanding genetic variations, disease mechanisms, and therapeutic targets, biochemical reagents enable precise and efficient genomic analysis. This capability supports the development of personalized therapies tailored to individual genetic profiles, augmenting the demand for high-quality reagents that ensure accuracy and reliability in genomic studies and clinical diagnostics.

The cell and tissue culture segment will garner a promising biochemical reagents market share by 2032. The demand for biochemical reagents is growing in the cell and tissue culture segment primarily due to advancements in biotechnology and pharmaceutical research. These reagents play a crucial role in maintaining cell viability, growth, and differentiation in controlled laboratory environments. With increasing applications in drug development, regenerative medicine, and bio-processing, biochemical reagents facilitate the cultivation and manipulation of cells and tissues for various research and therapeutic purposes. Their role in ensuring reproducibility and reliability in cell-based assays and experiments underscores their importance in advancing biomedical sciences and meeting the evolving needs of bio pharmaceutical industries.

Europe biochemical reagents market will grow at an impressive CAGR during the period from 2024 to 2032. The demand for biochemical reagents is experiencing growth in Europe, driven by robust investments in biotechnology and healthcare infrastructure. Europe focus on research and development in bio-pharmaceuticals and personalized medicine is amplifying the need for advanced biochemical reagents. Additionally, stringent regulatory frameworks that ensure high standards of research and diagnostics are fostering a favorable environment for biochemical reagents industry expansion. The increasing prevalence of chronic diseases and aging populations also contribute to heightened demand, as biochemical reagents play a critical role in disease diagnosis, treatment monitoring, and therapeutic development.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing R&D activities in life sciences and biotechnology
    • 3.2.1.2 Rising incidence of chronic and infectious diseases
    • 3.2.1.3 Technological advancements in biochemical research
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of biochemical reagents
    • 3.2.2.2 Stringent regulatory policies and quality control standards
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Porter's analysis
• 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Polymerase chain reaction reagent kits
• 5.3 Cell and tissue culture reagents
• 5.4 Electrophoresis reagents
• 5.5 Chromatography reagents
• 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 KEY trends
• 6.2 Drug discovery and development
• 6.3 Genomics
• 6.4 Proteomics
• 6.5 Diagnostics
• 6.6 Biotechnology research
• 6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Biotechnology & pharmaceutical companies
• 7.3 Academic and research institutes
• 7.4 Hospitals and diagnostic laboratories
• 7.5 Contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs)

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Agilent Technologies Inc.
• 9.3 Becton, Dickinson and Company
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Merck KGaA
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Johnson and Johnson
• 9.8 Siemens Healthineers AG
• 9.9 Thermo Fisher Scientific Inc.
• 9.10 Waters Corporation